Request Legal Help Now - Free
LAWSUITS NEWS & LEGAL INFORMATION

Heparin Legal News Articles & Interviews

View Lawyer Interviews only

China Continues Crackdown on Bogus Drug Manufacturers

China Continues Crackdown on Bogus Drug Manufacturers August 6, 2012. By Gordon Gibb.
Shanghai A report out of China Sunday pertaining to a government crackdown on counterfeit drugs and tainted food supplies would understandably leave health advocates in the US concerned about the quality of imports coming into the country from that part of the world.
Read [ China Continues Crackdown on Bogus Drug Manufacturers ]

The Heparin Contamination Hangover Continues to Persist

The Heparin Contamination Hangover Continues to Persist February 22, 2011. By Gordon Gibb.
Washington, DC It's a hangover of sorts from the Heparin Contamination scare of three years ago. That's when tainted heparin was traced back to the unsanitary production of pure heparin via unregulated sweatshops in China and the introduction of a mystery contaminant. But what of the checks and balances that would help to catch a problem and stop it dead in its tracks before it gets to market?
Read [ The Heparin Contamination Hangover Continues to Persist ]

Mother Believes Disabled Daughter Suffered Heparin Contamination

Mother Believes Disabled Daughter Suffered Heparin Contamination December 10, 2010. By Jane Mundy.
Detroit, MI In May 2009, Cathy's mentally disabled daughter was rushed to the hospital with severe abdominal pain and the doctors found blood clots. "Right away she was given Heparin IV and she started bleeding outwards—there was blood everywhere," says Cathy. "Then she had a heparin allergic reaction—her abdomen was severely swollen and covered in a scarlet rash.
Read [ Mother Believes Disabled Daughter Suffered Heparin Contamination ]

B. Braun Recalls Potentially Tainted Heparin

B. Braun Recalls Potentially Tainted Heparin December 4, 2010. By Charles Benson.
Irvine, CA California-based B. Braun Medical Inc. recently announced the recall of seven lots of heparin, an anticoagulant, due to concerns that they could be tainted with small amounts of oversulfated chondroitin sulfate (OSCS), according to the FDA.
Read [ B. Braun Recalls Potentially Tainted Heparin ]

Heparin Recall—Same Contamination, Different Time

Heparin Recall—Same Contamination, Different Time November 26, 2010. By Jane Mundy.
Los Angeles, CA The latest heparin recall by B. Braun Medical Inc. is the same problem that poisoned hundreds of patients in late 2007 and early 2008. How could this happen again? "Obviously it is the result of some sloppy work on the part of the supplier, Scientific Protein Laboratories, or B. Braun, or both companies," says attorney Roger Drake, with the law firm Baum, Hedlund, Aristei & Goldman.
Read [ Heparin Recall—Same Contamination, Different Time ]

Did Heparin Mix-Up with Insulin Contribute to Infant's Death?

Did Heparin Mix-Up with Insulin Contribute to Infant's Death? November 17, 2010. By Gordon Gibb.
Saskatoon, Saskatchewan Not long ago actor Dennis Quaid made headlines after his infant children were given an adult dose of heparin in the hospital, rather than the formulation meant for infants. An investigation determined the labels of the two formulations were too similar. Well, it has happened again—sort of. This time, in Canada. And this time, insulin was mistaken for heparin injection due to a similarity in the label.
Read [ Did Heparin Mix-Up with Insulin Contribute to Infant's Death? ]

Seven Lots of Heparin Recalled

October 29, 2010. By Lucy Campbell.
Washington, DC B. Braun Medical Inc. (B. Braun) was recently notified by its supplier, Scientific Protein Laboratories LLC (SPL), of a nationwide recall of a lot of Heparin Sodium USP Active Pharmaceutical Ingredient (API) sold to B. Braun because additional testing of retained crude heparin samples used by SPL to manufacture this single API lot indicated a trace amount of oversulfated chondroitin sulfate (OSCS) contaminant. As a result, B. Braun is initiating a voluntary recall of seven lots of heparin injection products to the healthcare provider level. These lots were manufactured in 2008 and will be expiring on October 31, 2010 and November 30, 2010.
Read [ Seven Lots of Heparin Recalled ]

Child Dies of Heparin Overdose, Investigation Launched

Child Dies of Heparin Overdose, Investigation Launched April 2, 2010. By Gordon Gibb.
Omaha, NE A two-year-old toddler died Wednesday after she was given too much heparin at a Nebraska hospital. Almariah Duque, who was in the hospital for multiple organ transplants and also recovering from gastrochisis, died on the afternoon of March 31 at the Nebraska Medical Center. She had been declared clinically dead that morning.
Read [ Child Dies of Heparin Overdose, Investigation Launched ]

Conflict of Interest Alleged Against FDA and Heparin Contamination

Conflict of Interest Alleged Against FDA and Heparin Contamination January 23, 2010. By Gordon Gibb.
Washington, DC An allegation of conflict of interest that grew out of the heparin contamination case of 2008 is still very much alive today. While patients became ill and died from tainted heparin injections, the director of the FDA's Center for Drug Evaluation and Research found herself embroiled in controversy.
Read [ Conflict of Interest Alleged Against FDA and Heparin Contamination ]

Family Files Suit after Texas Man Dies from Heparin Injection

Family Files Suit after Texas Man Dies from Heparin Injection January 13, 2010. By Charles Benson.
Lufkin, TX The family of a man who allegedly died from complications arising from a contaminated heparin injection has filed a product liability lawsuit against the makers of the blood thinning agent, Baxter, and the medical facility that administered the drug.
Read [ Family Files Suit after Texas Man Dies from Heparin Injection ]

Page: 1  2  3     Next»
Request Legal Help Now! - Free